Precedence Research Announced New Report on “Conjunctivitis Market – Global Industry Analysis, Size, Share, Trends, Revenue, Forecast 2021 to 2030”.
The global conjunctivitis market size is predicted to surpass around USD 6.85 billion by 2030 from USD 4.39 billion in 2020, exhibiting at a CAGR of 3.65% during the estimate period 2021 to 2030.
Get the sample copy of this report@ https://www.precedenceresearch.com/sample/1230
Factors such as increasing prevalence of conjunctivitis, increasing healthcare expenditure, rising exposure to allergens, highly contagious nature of conjunctivitis are driving the growth of conjunctivitis market. Moreover, Additional features that are expected to fuel this business are integration of latest technologies and growing investment by major players.
Smoking affects the ocular surface, resulting in redness, itchiness, and irritation of the eyes. This can cause atopic keratoconjunctivitis and allergic conjunctivitis due to decreased conjunctival sensitivity. Industrialization, especially the automobile industry, involves high levels of pollutants and chemicals. Exposure to diesel exhausts increases the density of inflammatory cells, such as IL-6 and intercellular adhesion molecule-1, leading to the development of allergic conjunctivitis. This will drive the growth of the conjunctivitis medication market, as more individuals will require treatment.
|Market Size||USD 6.85 billion by 2030|
|Growth Rate||CAGR of 3.65% From 2021 to 2030|
|Historic Data||2017 to 2020|
|Forecast Period||2021 to 2030|
|Segments Covered||Patients, Drug Class, Patients Type|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)|
- Among the type segment, allergic conjunctivitis dominated the overall market in 2020. High prevalence of allergic conjunctivitis due to high exposure to allergen is the foremost factors attributing to its large market share.
- The adults segment accounted for the major share of revenue in the patient type segment with more than 63% share in 2020 due to high incidence of conjunctivitis in adults. Pediatric segment is anticipated to grow at the uppermost CAGR through the forecast duration.
- Anti-histaminic accounted for the largest revenue in the drug-class segment. Use of anti-histaminic for the management of allergic conjunctivitis is the key reason for high market share. Steroid Drugs segment is expected to grow at the highest growth rate through the estimate duration.
- Allegran, Pfizer Inc, Atopix Therapeutics Ltd. accounted for a significant share of the global conjunctivitis market.
- Atopix Therapeutics Ltd.
- Ocular Therapeutix, Inc.
- Santen Pharmaceutical Co. Ltd.
- Boehringer Ingelheim
- Pfizer Inc
- Sun Pharma
- Sirion Therapeutics, Inc.
Ask here for customization study@ https://www.precedenceresearch.com/customization/1230
Overview of the Study
This market report studies market dynamics, status and outlook especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This research report offers scenario and forecast (revenue/volume). This report also studies global market prominence, competitive landscape, market share, growth rate, market dynamics such as drivers, restraints and opportunities, and distributors and sales channel.
This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers competitive scenario which comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.
Key Points of the Global Conjunctivitis Market Report:
The report provides a basic overview of the Conjunctivitis industry including its definition, applications, and manufacturing technology.
The report also explores the major international players in detail. In this part, the report presents the company profile, product specifications, capacity, and production value up to ‘2030 year’, along with the market shares for each company.
Through the statistical analysis, the study depicts the global market for Conjunctivitis including capacity, production, production value, cost/profit, and supply/demand from an international perspective.
Considering segmentation, the market is divided in terms of product, end-use, company, region, and other important aspects. Each of these categories forms an important base point for the competitive landscape analysis.
The report then estimates the market development and trends of the Conjunctivitis industry up to 2030.
The report hints at crucial information associated with new market developments being undertaken in the Conjunctivitis industry before evaluating its feasibility.
- Bacterial Conjunctivitis
- Viral Conjunctivitis
- Allergic Conjunctivitis
By Patients Type
By Drug Class
- Steroid Drugs
Reasons to Purchase this Report:
Estimates Conjunctivitis development trends with SWOT analysis
Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players
Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market’s expansion
Market dynamics scenario, along with growth opportunities for players in the years to come
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the mentioned forecast period
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Buy this Research Report study@ https://www.precedenceresearch.com/checkout/1230
You can place an order or ask any questions, please feel free to contact at firstname.lastname@example.org | +1 9197 992 333
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
For Latest Update Follow Us: